LNWWM
Laird Norton Wetherby Wealth Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Buy |
+1,511
| New | +$229K | 0.01% | 818 |
|
|
2024
Q4 | $296K | Sell |
1,603
-68
| -4% | -$12.6K | 0.01% | 704 |
|
|
2024
Q3 | $329K | Sell |
1,671
-36
| -2% | -$7.09K | 0.02% | 698 |
|
|
2024
Q2 | $353K | Hold |
1,707
| – | – | 0.02% | 648 |
|
|
2024
Q1 | $463K | Sell |
1,707
-73
| -4% | -$19.8K | 0.02% | 581 |
|
|
2023
Q4 | $421K | Buy |
1,780
+10
| +0.6% | +$2.36K | 0.02% | 602 |
|
|
2023
Q3 | $347K | Sell |
1,770
-139
| -7% | -$27.2K | 0.02% | 633 |
|
|
2023
Q2 | $401K | Buy |
1,909
+8
| +0.4% | +$1.68K | 0.02% | 615 |
|
|
2023
Q1 | $384K | Sell |
1,901
-26
| -1% | -$5.25K | 0.02% | 624 |
|
|
2022
Q4 | $420K | Buy |
1,927
+23
| +1% | +$5.01K | 0.03% | 573 |
|
|
2022
Q3 | $375K | Sell |
1,904
-46
| -2% | -$9.06K | 0.03% | 579 |
|
|
2022
Q2 | $417K | Buy |
1,950
+157
| +9% | +$33.6K | 0.03% | 554 |
|
|
2022
Q1 | $509K | Buy |
1,793
+44
| +3% | +$12.5K | 0.03% | 515 |
|
|
2021
Q4 | $659K | Sell |
1,749
-188
| -10% | -$70.8K | 0.04% | 419 |
|
|
2021
Q3 | $799K | Sell |
1,937
-13
| -0.7% | -$5.36K | 0.05% | 355 |
|
|
2021
Q2 | $721K | Buy |
+1,950
| New | +$721K | 0.04% | 384 |
|
|
2021
Q1 | – | Sell |
-1,935
| Closed | -$483K | – | 799 |
|
|
2020
Q4 | $483K | Buy |
+1,935
| New | +$483K | 0.03% | 469 |
|